Eric Ponder, PA
Medical · Jacksonville, FLNPI 1447761630
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $40,733 of the $66,853 with a category attached, or 60.9%. AbbVie accounts for 74.0% of it on its own, with 55 other manufacturers making up the rest. Reporting peaked in 2021 at $21,161 and has fallen 52.5% since, to $10,041 in 2025. Among medical clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,005 payments — averaging $66.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$50K
- Biohaven Pharmaceutical Holding Company Ltd.$2K
- Jazz Pharmaceuticals Inc.$1K
- Amgen$1K
- Teva Pharmaceuticals USA, Inc.$1K
- Pfizer$1K
- plus $10K from 50 others
What the payments were for
- Consulting fees$3,6906%
- Speaking & faculty fees$40,73361%
- Travel & lodging$2,4634%
- Food & beverage$19,66729%
- Education$2990%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$66,853 in reported general payments places this provider in the 95th percentile of 2,031 medical providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| AustedoDeutetrabenazine | 12 | $172,013 |
| IngrezzaValbenazine Tosylate | 18 | $149,399 |
| CopaxoneGlatiramer Acetate | 14 | $114,818 |
| UbrelvyUbrogepant | 47 | $75,145 |
| Nurtec OdtRimegepant Sulfate | 52 | $70,937 |
| RexultiBrexpiprazole | 31 | $63,732 |
| QuliptaAtogepant | 44 | $60,783 |
| Aimovig AutoinjectorErenumab-Aooe | 45 | $39,237 |
| Emgality PenGalcanezumab-Gnlm | 34 | $24,176 |
| BotoxOnabotulinumtoxina | 14 | $18,279 |
| Ajovy AutoinjectorFremanezumab-Vfrm | 17 | $13,510 |
| GraliseGabapentin | 17 | $10,532 |
| Gabapentin | 135 | $5,215 |
| Memantine Hcl | 139 | $4,183 |
| Sumatriptan Succinate | 131 | $2,864 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Teva Pharmaceuticals USA, Inc.Austedo, Copaxone | $1,187 | $286,83126 claims |
| AbbVieUbrelvy, Qulipta, Botox | $49,500 | $154,207105 claims |
| Neurocrine Biosciences, Inc.Ingrezza | $594 | $149,39918 claims |
| PfizerNurtec Odt | $1,092 | $70,93752 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $209 | $63,73231 claims |
| Upsher-smith Laboratories LLCTopiramate | $147 | $1,22290 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,031 medical providers in Florida.
Other medical in Jacksonville
- Kristen DixonJacksonville$54K
- Amanda MichaudJacksonville$45K
- Paul DuffJacksonville$35K
- Ina SansonJacksonville$15K
- Gary RubinRockledge$2.1M
- Shanna MirantiNaples$415K
- Krystie LennoxBoca Raton$245K
- Jihan RamadanWellington$238K
- Ilanit SamuelsMiami$211K
- Erin DouceyWinter Haven$202K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.